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Abstract 
Momordica charantia Linn. is an edible plant, used in various countries for the treatment of several diseases. 
For the purpose of this research, aqueous extract of air dried leaves of M. charantia was used. The aqueous leaf 
extract was administered (at 80mg/kg, 100mg/kg and 120mg/kg of body weight) to male albino rats for 90 days. 
After which, the bone marrow and sperm cells were observed for micronuclei, sperm count and sperm head 
abnormalities. The results from this study showed that increased dosage of the aqueous leaf extract produced a 
decrease in micronuclei observed among the groups, indicating that M. charantia has some anti-mutagenic 
potentials and it is able to inhibit chromosomal breakages. Contrary to its effects on the bone marrow cells, the 
results from the sperm analyses indicates that it has teratogenic potentials by reducing sperm production and 
altering sperm morphology. 
Keywords: Anti-Mutagenic; Micronucleus; Momordica charantia Linn; Sperm Count; Sperm Head 
Abnormality; Teratogenic. 
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1. Introduction 
Momordica charantia Linn. belongs to the family Cucurbitaceae and it is commonly cultivated in the tropics 
and sub-tropics. Due to the characteristic bitter taste of M. charantia, it is known as Balsam pear, Bitter melon 
or Bitter gourd [1-2]. In addition to its use as an edible vegetable, various parts of the herb including the leaves 
and fruits are being used to treat various diseases [2-4]. In different communities, the leaves and fruits of M. 
charantia are used to treat and prevent diseases such as diabetes, liver diseases, ulcer, constipation, malaria, 
kidney stones, skin problems and so on [4-5]. Therefore, there is need to ascertain the genotoxic potentials of 
this plant. Though various studies are being done regularly to determine the genotoxic potentials of the fruits 
and seeds, yet not much has been done to determine that of the leaves. Hence, this research work was aimed at 
determining the mutagenic and teratogenic potentials of the leaves of Momordica charantia Linn. 
2. Materials and methods 
2.1. Plant material and extraction 
Fresh leaves of M. charantia were collected during the wet season from Badagry, Lagos, Nigeria. The plant was 
identified at the Herbarium of the University of Lagos, Nigeria and a voucher number-LUH 6469 was assigned. 
The leaves were air-dried and blended to obtain a fine powder. The fine powder was boiled with distilled water 
in an uncovered beaker for about 15 minutes and filtered to obtain an aqueous decoction. The amount of dry 
extract in a ml of the decoction was ascertained, in order to determine the volume of extract to be administered 
to experimental animals. 
2.2. Ethical approval 
The research was approved by the Research Grant and Experimentation Ethics Committee of the College of 
Medicine, University of Lagos, South-West, Nigeria.  
2.3. Experimental animals and procedure 
24 male albino rats (Rattus novergicus- Sprague Dawley) weighing between 105.19-242.73g were used as 
experimental animals. The rats used were purchased from Komad Farm Limited, Sango Ota, Ogun State, 
Nigeria. The rats were housed in conventional plastic cages, at the Animal house of the department of Cell 
Biology and Genetics, University of Lagos; with 12hrs of light and dark cycle. The rats were fed with rat chow 
ad libitum and unlimited supply of water. Acclimatization of the rats to the new environment was carried out for 
2 weeks before the onset of the research work. After determination of the lethal dosage (LD50) of the aqueous 
leaf extract to be 140mg/kg, the male rats were placed in 4 groups (A, B, C, D). Group A being the control, were 
administered with distilled water alone; B: were administered with 80mg/kg body weight of each rat; C: were 
administered with 100mg/kg body weight; while D: were administered with 120mg/kg. Administration of 
extract was done using oral gavage method. The rats were exposed daily to the plant extract for 90 days. On day 
91, sacrificing of the rats was carried out through the cervical dislocation method and the required organs 
removed for micronucleus and sperm cell analyses. 
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2.4. Sample collection and processing 
2.4.1. Micronucleus test 
The procedure utilized for the micronucleus test was according to standard protocol [6-7]. For each rat, both 
femurs were carefully removed and rinsed with physiological saline. The bone marrow was flushed out of the 
femur using Fetal Bovine Serum (Sigma Aldrich Cheme GmbH, Germany) into sterilized eppendoff tubes. The 
bone marrow was centrifuged at 2000rpm for 10 minutes. The cells were smeared on clean slides, followed by 
staining using May-Grunwald and Giemsa stains. Four slides were prepared per animal and a total of 1000 cells 
were evaluated per rat (at 250 cells per slide). The cells were viewed using an oil immersion lens (1000X); in 
order to microscopically score the number of micronuclei in polychromatic erythrocytes (PCE). 
2.4.2. Sperm Count Analysis 
The male rats were sacrificed and their epididymides carefully removed in accordance to the protocol of [8]. 
The contents of one epididymis for each rat, was gently emptied into a sterile specimen tube containing formol 
saline to a dilution of 1:10. The sperm cells were counted with a haemocytometer at 400X using a light 
microscope, after which the sperm concentration/count was evaluated for each rat using the guidelines of [9]. 
2.4.3. Sperm Morphology Assay 
For each rat, the other epididymis was utilized for morphology assay following a modification of standard 
procedure [10-11]. The epididymis was finely minced in physiological saline and filtered, in order to remove 
tissues of the epididymis. Slides (4 slides per animal) were prepared by smearing the cell suspension on grease-
free slides, followed by staining with Giemsa stain. 1000 cells per rat were evaluated for abnormalities, at 400X 
magnification with the use of a light microscope. 
3. Results 
3.1. Micronucleus 
It is observed from Table 1, that increase in the dose of the treatment resulted in a decrease in the mean of 
micronuclei observed (Fig. 1). In addition, each treatment in Table 1 is denoted by a separate letter, thereby 
indicating that at P < 0.05, the treatment produced significantly different effects among the groups. 
3.2. Sperm Count 
Results from Table 1 shows that as the dosage of the treatment increased, there was a decrease in group mean 
for sperm count. An observation of the different letters used in denoting each treatment, indicates that increasing 
doses of the treatment, produced significant differences among the groups at P < 0.05. 
3.3. Sperm Head Abnormality 
The results shown in Table 1, reflects the effect of the treatment on sperm morphology. These results show that 
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increasing doses of the treatment had significant effects (at P < 0.05) on the morphology of the sperms. Thereby 
resulting to increase in the number of sperms with abnormal head observed (Figs. 3-6): pin-shaped head, sickled 
hook head, sperm heads without hook, sperm cells with knobbed head and skewed head when compared with 
the normal hooked head of the control group (Fig. 2). 
Table 1: Showing the Mean and Standard Deviation for Micronucleus, Sperm Count and Sperm Head 
Abnormality. 
TREATMENT MNPCE (MEAN±SD) SC (X106) (MEAN±SD) SHA (MEAN±SD) 
CONTROL 23.667±3.933d 114.667±4.457d 17.500±4.087a 
80 mg/kg 14.667±1.506c 92.917±5.616c 126.167±5.269b 
100 mg/kg 9.167±2.041b 77.167±4.719b 146.000±7.950c 
120 mg/kg 3.500±1.517a 55.500±7.589a 203.333±13.604d 
REMARK Significant Significant Significant 
MNPCE: Micronucleus in each Polychromatic Erythrocyte; SC: Sperm Count; SHA: Sperm Head Abnormality; 
SD: Standard Deviation; a: treatment with lowest figure; d: treatment with highest figure. Mean±SD followed 
by the same letter of alphabet are not significantly different at P < 0.05. 
 
Figure 1: A - An Immature Erythrocyte with Micronucleus, B – A Normal Immature Erythrocyte. 
B 
A 
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Figure 2: Arrow Showing Cells with Normal Sperm Head and hook. 
 
Figure 3: Arrows Showing Sperm Cells with Abnormally Skewed Head and Hooked at wrong angle. 
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Figure 4: Arrow showing Sperm Cell with a Knobbed Head. 
 
Figure 5: A - Sperm Cell with a sickled hook, B - Sperm Cells without hook. 
 
A 
B 
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Figure 6: Abnormal Sperm Cell with a Pin-Shaped Head. 
 
4. Conclusion 
To determine the genotoxicity of a substance several assays are employed, some of which are the micronucleus 
test, sperm count and sperm head abnormality assays. The micronucleus test is used to determine the mutagenic 
potential of a substance, while the sperm cells are used to ascertain its teratogenic potential. Therefore, these 
assays were utilized in determining the mutagenic and teratogenic potentials of aqueous extract of M. charantia 
leaves.  An observation of the results for the micronucleus test showed that the rats administered with aqueous 
leaf extract of M. charantia, possessed fewer number of MNPCE. It is also observed that as the dosage 
increased from 80mg/kg to 120mg/kg, there was a significant decrease in the mean MNPCE per treatment 
(Table 1). This indicates that M. charantia inhibits chromosomal breakages and prevents the development of 
micronuclei in PCE. Thereby, establishing the fact that M. charantia possesses anti-mutagenic potentials as 
stated in a previous study conducted using aqueous fruit extract [12]. Upon observing the sperm cells of these 
rats, it is observed that the mean sperm count decreases with increased dosage (Table 1); with 120mg/kg having 
the lowest sperm count. This implies that the aqueous leaf extract of M. charantia inhibits sperm production; 
similar to the results obtained from a study conducted on the sperm cells using methanolic seed extract [13]. 
Likewise, the results of the sperm head morphology (Table 1), shows that aqueous leaf extract of M. charantia  
induced an increase in the production of sperms with abnormally shaped heads (Figs. 3-6); as the dosage 
increases [14].  The results on the sperm cells invariably imply that the leaves of M. charantia, has teratogenic 
potentials. The results from this study and those of previous studies, imply that the consumption of M. charantia 
can induce male infertility. Therefore, caution should be applied in the consumption of this plant and its use in 
the treatment of diseases. 
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